Document:

ASSET PURCHASE AGREEMENT

 

This ASSET PURCHASE AGREEMENT, dated
as of the 13th day of September, 2013 (the “Agreement”) is between Revive Bioscience Inc. and ( the “Vendor”),
Axxess Pharma Inc. (the “Purchaser”).

 

WHEREAS, the
Vendor desires to sell to the Purchaser, and the Purchaser desires to purchase from the Vendor substantially all of the
assets of the Vendor used in the operation of the Vendor’s distribution of Tapout products business owned and operated by
the Vendor (the “Business”), upon the terms and subject to the conditions set forth herein;

 

AND WHEREAS the
Vendor and Purchaser entered into a letter of intent dated the 2nd day of May , 2013 as amended (the “Letter of
Intent”) to summarize the general terms and conditions of their agreement.

 

AND WHEREAS,
this Asset Purchase Agreement constitutes the “Definitive Purchase Agreement” described in the Letter of Intent.

 

NOW, THEREFORE,
in consideration of the mutual agreements and covenants herein contained and intending to be legally bound hereby, the parties
hereto agree as follows:

 

ARTICLE I

 

DEFINITIONS

 

Section 1.01         Definitions.
The following terms, as used herein, have the following meanings:

 

(a)          “Affiliate”
of any Person means any Person that controls, is controlled by, or is under common control with such Person. As used herein, the
term “control” (including the terms “controlling,” “controlled by” and “under common
control with”) means the possession, directly or indirectly, of the power to direct or to cause the direction of the management
and policies of a Person, whether through ownership of voting securities or other interests, by contract or otherwise.

 

(b)          “Business”
means the business of Vendor as currently conducted, and includes the Vendor’s Tapout products distribution business owned
and operated by the Vendor under the TAPOUT trade-name and operated by the Vendor.

 

(c)          “Business
Confidential Information” means any confidential information transferred from Vendor to Purchaser hereunder that pertains
to the Business, technical data, trade secrets or know-how, including, but not limited to, research, product plans, products, services,
customers, customer lists, markets, Software, Goodwill, developments, inventions, processes, formulas, technology, designs, drawings,
marketing, finances or other information relating to the Business. The term “Business Confidential Information” does
not include information that (i) is or becomes available on a non-confidential basis from a source that is not under an obligation
(whether contractual, legal or otherwise) to keep such information confidential; (ii) becomes generally available to the public
other than as a result of a disclosure in violation of the terms of this Agreement or a duty of confidentiality or (iii) is independently
developed without reference to the Business Confidential Information.

 

(d)          “Cash”
means all cash, bank balances, moneys in the possession of banks and other depositories, term or time deposits, guaranteed investment
certificates, treasury bills, other securities and other similar cash or cash-equivalent items owned by the Vendor as of the Date
of Closing.

 

(e)          “Closing”
means the completion of the purchase and sale contemplated in this Agreement.

 

(f)          “Date
of Closing” and “Closing Date” mean the date of the Closing, as described in Section 2.08.

 

    	 

    	 

    

 

(g)          “Disclosure
Schedule” means the schedule attached hereto and provides any matters disclosed by the Vendor to the Purchaser prior
to the Closing Date and the particulars of any agreement, understanding or arrangement among the Purchaser and Vendor with respect
thereto

 

(h)          “Computer
Hardware and Software” means all computer hardware and Software utilized by the Business.

 

(i)          “Contracts”
means the full benefit of all contracts providing for the supply of goods and services by the Business.

 

(j)          “Excluded
Assets” has the meaning assigned in Section 2.03.

 

(k)          “Goodwill”
means all goodwill associated with the Business, including without limitation, all of the Vendor’s right, title and interest
in and to the trade names “TAPOUT”, together with the exclusive right of the Purchaser to represent itself as carrying
on the business of the Vendor in continuation of and in succession to the Vendor and the exclusive right to use any words indicating
so, including “TAPOUT, Trademarks, client lists, mailing lists, telephone and fax numbers, URLs, websites and email addresses
associated with the URLs.

 

(l)          “Intellectual
Property” means all trademarks, registered and unregistered, all service marks, all designs, slogans, and logos (collectively,
“Trademarks”), trade names, Internet domain names, and general intangibles of like nature, together with all
Goodwill, registrations and applications related to the foregoing; all patents and patent applications (including any continuations,
divisionals, continuations-in-part, renewals and reissues therefor) (collectively, “Patents”); all copyrights
(including any registrations and applications for any of the foregoing) and associated moral rights including copyrights in content
of websites and webpages; all rights in Software; all “mask works” (as defined under 17 USC ' 901 and under applicable
Canadian laws) and any registrations and applications for “mask works”; all Business Confidential Information, trade
secrets and other confidential information, know-how, proprietary processes, formulae, algorithms, models, and methodologies (collectively,
“Trade Secrets”); any other proprietary or intellectual property rights of any kind, whether arising under the
laws of Canada, the United States or any nation, state, province or jurisdiction, and all rights or causes of action for infringement,
misappropriation, misuse dilution or unfair trade practices associated with the foregoing.

 

(m)          “Inventory”
means all saleable/usable inventory of or relating to the Business as of the Date of Closing, including all raw materials, manufacturing
supplies, packaging materials, work in process and finished goods. Inventory excludes any items that: (i) are spoiled; (ii) are
past their expiry or due date; (iii) have not been paid for by the Vendor or (iv) prior to the Date of Closing, are not used by
the Business in the ordinary course.

 

(n)          “Knowledge”
concerning a particular subject, area or aspect of Vendor's business affairs shall mean the knowledge of each of the officers and
directors of Vendor and all knowledge which was or should have been obtained upon reasonable inquiry by such persons.

 

(o)          “Leases”
means any and all real property leases, assignments or subleases related to the use or occupation of the leased Premises.

 

(p)          “Leased
Equipment” means, the leases of any and all equipment, machinery and vehicles currently leased by the Vendor and used
with respect to the Business, and which may be requested by Purchaser before closing to be included in the purchase and sale contemplated
herein at or before Closing, subject to the parties obtaining the consent of the lessor(s) of such leased equipment.

 

(q)          “Lien”
means any lien (including Tax liens), proxy, voting trust arrangement, mortgage, pledge, security interest, collateral security
agreement, financing statement (and similar notices) filed with any Governmental Authority, claim, charge, equities, title defect,
option, right of first refusal, restrictive covenant or other limitation or restriction on transfer of any nature whatsoever or
other lien or encumbrance.

 

    	 

    	 

    

 

(r)          “Machinery and Equipment”
means all machinery, equipment, fixtures, leasehold improvements, signage, accessories and supplies of any kind owned by
the Vendor and used in connection with the Business. Schedule 2.02 contains a list of Machinery and Equipment.

 

(s)          “Material
Adverse Effect” or “Material Adverse Change” with respect to a Party means a material adverse effect
on, or material change in, the condition (financial or otherwise), business, assets, results of operations or prospects of such
Party as a result of a breach, default or deficiency in the satisfaction of any covenant, representation or warranty which might
reasonably:

 

(i)          give
rise to an aggregate remedial cost (including consequential loss and loss of profit) of more than $5,000.00, in any individual
instance, or more than $5,000.00 collectively in any greater number of instances, where all such instances arise as a result of
multiple breaches of the same covenant, representation or warranty; or

 

(ii)         where
no adequate remedy is reasonably available, result in disturbance in the ordinary conduct of the Business of an aggregate cost
properly attributable to such disturbance (including consequential loss and loss of profit) of more than $5,000.00.

 

(t)          “Office
Furniture” means all office furniture and fixtures used by the Business which are owned by the Vendor and currently located
at the Premises. Schedule 2.02 contains a list of Office Furniture.

 

(u)          “Party”
or “Parties” means any of Vendor or Purchaser.

 

(v)          “Permitted
Liens” means (i) Liens for Taxes that are not yet due; and (ii) mechanic's, materialman's, carrier's, repairer's and
other similar Liens arising or incurred in the ordinary course of business.

 

(w)          “Person”
means any individual, corporation, partnership, firm, association, joint venture, joint stock company, trust, unincorporated organization
or other entity, any Governmental Body, or any government or regulatory, administrative or political subdivision or agency, department
or instrumentality thereof.

 

(x)          “Purchased
Assets” has the meaning assigned in Section 2.02 and includes the Premises..

 

(y)          “Software”
means any and all (i) computer programs, including any and all software implementation of algorithms, models and methodologies,
whether in source code or object code form, (ii) databases and compilations, including any and all data and collections of data,
(iii) unit tests of all implementations, and (iv) all existing documentation, including user manuals and training materials, relating
to any of the foregoing.

 

(z)          “Tax”
or “Taxes” means any net income, alternative or add-on minimum tax, gross income, gross receipts, sales, value-added,
use, ad valorem, franchise, capital, paid-up capital, profits, license, withholding, payroll, employment, excise, severance, stamp,
occupation, premium, property, environmental or windfall profit tax, custom, duty, transfer, documentary or other tax, governmental
fee or other like assessment or charge of any kind whatsoever, any information reporting or back-up withholding obligation, liability
or penalty, together with any interest, penalty, addition to tax or additional amount imposed by any governmental authority (domestic
or foreign) responsible for the imposition of any such tax, whether disputed or not.

 

(aa)         “Tax
Act” means the Income Tax Act (Canada) as it is amended and superceded from time to time.

 

(bb)         “Tax
Return” means all federal, state, local and foreign returns and reports (including elections, claims for refunds, declarations,
disclosures, schedules, estimates and information returns) required to be filed with respect to Taxes.

 

    	 

    	 

    

 

ARTICLE II

 

PURCHASE AND SALE OF THE BUSINESS

 

Section 2.01        Purchase and Sale of Assets.
Purchase and Sale. Upon the terms and subject to the conditions set forth in this Agreement, the Purchaser agrees to
purchase from the Vendor, and the Vendor agrees to sell, transfer, assign, convey and deliver to the Purchaser all of the right
title and interest in, to and under the Purchased Assets free and clear of all Liens. The Parties agree that the Excluded Assets
are excluded from the asset sale contemplated hereby and will be retained by the Vendor.

 

(b)           Liabilities not Assumed. Save
and except for assuming specific obligations of the Vendor by virtue of being the purchaser of the Vendor’s right,
title and interest in and to the Purchased Assets, and except for the Purchaser’s limited obligations regarding trade
payables of the Vendor owing as of the Date of Closing as listed in Schedule 2.4 hereto, the Purchaser shall not assume nor
be responsible in any way to perform any of the obligations or pay any of the liabilities of the Vendor or of the Business
for the period prior to the Date of Closing. For greater certainty, other than with respect to liabilities being assumed by the
Purchaser, the Vendor shall be responsible for and shall satisfy any and all liabilities relating to the operation of the Business
up and/or to the Date of Closing..

 

Section 2.02        Purchased Assets. The
assets to be sold by the Vendor and purchased by the Purchaser (the “Purchased Assets”) include all assets
of the Business, except the Excluded Assets. Without limiting the generality of the foregoing, included within the Purchased Assets
shall be:

 

		a)	License Agreement between ABG TapouT LLC and Samaritan Holdings Limited effective April 29, 2011

		b)	Health Canada Product Licence Issuance NPN 80031713 – Tapout Muscle Recovery and Health
Canada Product Licence Issuance NPN 80032092 – Tapout Muscle Recovery, together with all documentation, formulations and
specifications related to and necessary for the manufacture of such products (hereinafter collectively the “NPN’s”);

		c)	All such other Health Canada product licences which may be in the possession of the Vendor as of
the Date of Closing;

		d)	All of the intellectual property of the Vendor relating to the Business (the “Intellectual
Property”) including all patents whether issued, pending, expired or in the process of being reinstated, including but not
limited to United States Patent No. 6,444,238 Pain Relief Composition and Method of Relieving Pain DBC File No. R1261.101.101 including
all associated formulation worksheets renewed for a period of at least one year following its current expiry date of March 3, 2014;
		e)	All websites and specifically the URL known as tapoutmusclerecovery.com;
		f)	All distribution contracts to which the Vendor is a party
and which are the subject of negotiation in both Canada and the United Statement (the “Distribution Contracts”);
		g)	All office furniture and fixtures used by the Business which are owned by the Vendor and currently
located at the Vendor’s Premises as listed in Schedule 2.02 hereto (the “Office Furniture”);
		h)	All machinery, fixtures, leasehold improvements, signage, accessories and supplies of any kind
owned by the Vendor and used in connection with the Business as listed in Schedule 2.02 hereto (the “Machinery and Equipment”);
		i)	All prepaid expenses relating to the Business as of the
Date of Closing;
		j)	All saleable/usable inventories of or relating to the
Business as of the Date of Closing, including all raw materials, manufacturing supplies, packaging materials, work in process
and finished goods (the “Inventory”);
		k)	All computer hardware and software utilized by the Business (the “Computer Hardware and Software”);
for greater certainty, where the software is licensed to the Vendor, the Vendor’s obligation under this paragraph shall be
limited to an assignment of the license to the Purchaser;
		l)	All goodwill associated with the Business, including
without limitation, all of the Vendor’s right, title and interest in and to the trade names “TAPOUT”, together
with the exclusive right of the Purchaser to represent itself as carrying on the business of the Vendor in continuation of and
in succession to the Vendor and the exclusive right to use any words indicating so, including trademarks, client lists, mailing
lists, telephone and fax numbers, URLs, websites and email addresses associated with the URLs (the “Goodwill”);

 

    	 

    	 

    

 

		m)	Copies of all necessary business and financial records solely relating to the Business and the
Purchased Assets (as defined below), including without limitation all customer and supplier lists and records, all operating manuals,
records, all personnel and payroll records solely relating to the employees being offered employment by the Purchaser and who accept
an offer of employment and all information required to conduct the Business as a going concern going forward;
	 	 	 
		n)	At the request of the Purchaser, the leases of any and all equipment, machinery and vehicles currently
leased by the Vendor and used with respect to the Business, subject to the parties obtaining the consent of the lessor(s) of such
leased equipment failing which the Purchaser shall make payment of all amounts due under such lease as the vendor’s agent
and will indemnify the Vendor against any claims by the lessor attributable to the period after the Date of Closing (the “Leased
Equipment”);
	 	 	 
		o)	Any and all real property leases, assignments or subleases related to the use or occupation of
the leased Premises set out below (the “Leases”);
	 	 	 
		p)	The full benefit of all contracts providing for the supply of goods and services by the Business,
subject to the Purchaser’s review and acceptance of such contracts prior to the Date of Closing (the “Contracts”);
	 	 	 
		q)	The exclusive right to represent the Purchaser as carrying on the Business as successor to the
Vendor;
	 	 	 
		r)	All of the Vendor’s warranty rights, if transferable,
against manufacturers or suppliers relating to any of the Purchased Assets,
		s)	All deferred income taxes and income taxes recoverable;
		t)	All accounts receivable due and owing from any person,
firm or corporation not acting at arm’s length from the Vendor;
		u)	All extra-provincial, sales, excise or other licenses or registration issued to or held by the
Vendor whether in respect of the Business or otherwise and;
	 	 	 
		v)	All vehicles and/or rolling stock used in the operations of the Business as listed in Schedule
2.02 hereto.

 

(collectively, the “Purchased Assets”).

 

And all other specific assets listed in Schedule
2.02 hereto.

 

Section 2.03        Excluded Assets. The following assets owned
by the Vendor as of the Closing Data shall be specifically excluded from the purchase and sale of assets provided for in
this Agreement (the “Excluded Assets”):

 

		(a)	The minute books of the Vendor;

 

		(b)	All original corporate, financial, taxation and other
records of the Vendor not pertaining exclusively or primarily to the Business or the Purchased Assets;

 

		(c)	All proceeds receivable from life insurance policies
of the life of any director, officer, employee or shareholder of the Vendor;

 

		(d)	Pre-paid rent;

 

		(e)	Duty drawbacks;

 

		(f)	Recoverable HST on bad debts;

 

    	 

    	 

    

 

		(g)	All cash, bank balances, moneys in the possession of
banks and other depositories, term or time deposits, guaranteed investment certificates, treasury bills, other securities and
other similar cash or cash equivalent items owned by the vendor as of the Closing Date;

 

		(h)	Accounts payable;

 

		(i)	All specific assets listed in Schedule 2.03; and

 

		(j)	All and any debts whatsoever not specifically and otherwise
expressly assumed by the Purchased;

 

Section
2.04        Trade Payables The Vendor shall discharge all liabilities and debts
of the Vendor prior to Closing .subject only to the obligation of the Purchaser to make payment of the liabilities listed in
Schedule 2.04 hereof totaling the all-inclusive sum of Fifty-Five Thousand Dollars ($55,000.00) (hereinafter the “Trade
Payable”) which sum shall be paid by the Purchaser to the listed creditors of the Vendor forthwith upon the Closing of
this transaction. The Purchaser shall in no manner be liable to make any payment whatsoever to any of the creditors listed in
Schedule 2.04 if this transaction should not close. Upon the Purchaser making payment to the listed creditors, the Vendor
shall be responsible for obtaining full and final release in its favour from each listed creditor so paid evidencing the
discharge of said debt and there being no further liability to such creditor and the Vendor shall provide evidence of same to
the Purchaser within ten (10) business days of the Closing of this transaction. The obligation of the Purchaser to make
payment of the Trade Payables is conditional upon the Vendor delivering a written agreement with each creditor prior to
Closing evidencing the reduction of the total liability to the Trade Payables to an all inclusive sum of Fifty-Five Thousand
Dollars ($55,000.00) to be paid on or immediately after the Closing of this transaction. Should the Vendor fail to
provide same prior to the Closing Date, the Purchaser shall be entitled, in its full unfettered discretion, not to complete
the transaction contemplated by this Agreement.

 

Section 2.05        Un-assignable Contracts.
The Purchaser shall not assume any liability with respect to any contract the Vendor is party to which is not or cannot
be assigned to the Purchaser.

 

Section 2.06        Purchase Price. In
consideration of the sale, transfer, assignment, conveyance and delivery by Vendor of the Purchased Assets, the Purchaser
shall issue to the Vendor’s Shareholders as listed in Schedule 2.06 hereto and in the proportions set out therein, Six Million
and Four Hundred and Fifty Thousand (6,450,000) common shares of the Purchaser (subject to any applicable restrictions on such
common shares) having an approximate value of $XX as of the date of this Agreement. For the purposes hereof, the parties acknowledge
that the number of shares issued to the Vendor is equivalent to approximately fifteen percent (15%) of the Purchaser’s Share
Capital, as defined in Article 4.05.

 

Section 2.07        Bonus. The Vendor shall
be entitled to a bonus equal to Two Million and One Hundred and Fifty Thousand (2,150,000) commons shares of the Purchaser
(equivalent to five percent (5%) of the Purchaser’s Share Capital , as defined in Article 4.05 hereof) in each of the following
two cases:

 

(a)          if
the Purchaser or any related entity raises Five Hundred Thousand Dollars ($500,000.00) which has been paid in by way of private
placements within the first six months of the Date of Closing; and/or

 

(b)          if
the Purchaser or any related entity, has raised One Million and Five Hundred Thousand Dollars ($1,500,000.00) which has been
paid in by way of private placements and Robert Tallack procures on-line sales in favour of the Purchaser or
any related entity in excess of One Million dollars ($1,000,000.00) within the first eighteen (18) months of the Date
of Closing.

 

Section 2.08        Allocation of Purchase
Price. The allocation of the purchase price with respect to the value of the Purchased Assets shall be as set out in
Schedule 2.08. The Vendor and Purchaser agree that the value so attributed to the Purchased Assets is the respective fair market
values of those Assets and further agree to file in mutually agreeable form all elections required or desirable under the Income
Tax Act (Canada) in respect of those allocations.

 

    	 

    	 

    

 

Section 2.09        Date of Closing. The
closing of the transactions contemplated by this Agreement (the “Closing”) shall take place at the offices
of the solicitor for the Purchaser at 1:00 P.M., local time, on September 30, 2013 or at such earlier or later date and time or
place as to which the Parties shall agree in writing (the “Date of Closing”).

 

Section 2.10        Vendor’s
Deliveries.         At the Closing, the Vendor will deliver to the Purchaser
or its designees:

 

		(a)	a duly executed bill of sale with respect to the Purchased
Assets;

 

		(b)	duly executed documents properly effecting the assignment
of the leases of the Leased Equipment, the NPN’s, the Intellectual Property and the Contracts, the Distribution Contracts,
the Goodwill and all other Purchased Assets to the Purchaser;

 

		(c)	all certificates, opinions and documents required to
be delivered by the Vendor pursuant to Section 6.01;

 

		(d)	copies of all consents, approvals, authorizations and
orders required to be obtained by the Vendor hereunder at or prior to the Closing;

 

		(e)	the non-competition agreements;

 

		(f)	releases from each creditor listed on Schedule 2.04;

 

		(g)	the election contemplated by Section 8.01; and

 

		(h)	such other documents and instruments as Purchaser may
reasonably request and all other previously undelivered documents, instruments and writings required to be delivered by the Vendor
to the Purchaser at or prior to Closing pursuant to this Agreement or otherwise required in connection herewith; and

 

Section 2.11       Purchaser’s
Deliveries. The Purchaser will deliver to the Vendor or its designees:

 

		(a)	Share certificates representing the Purchase Price;

 

		(b)	Confirmation of Fifty Five Thousand dollars ($55,000.00)
being held in escrow by Purchasers counsel, to pay the list of creditors;

 

		(c)	Current capitalization table provided by Purchasers official
Transfer Agent, attached as a schedule to this agreement;

 

		(d)	all certificates and documents required to be delivered
by Purchaser pursuant to Section 6.02;

 

		(e)	copies of all consents, approvals, authorizations and
orders required to be obtained by Purchaser hereunder at or prior to the Closing;

 

		(f)	the election contemplated by Section 8.01; and

 

		(g)	such other documents and instruments as Vendor may reasonably
request and all other previously undelivered documents, instruments and writings required to be delivered by Purchaser to Vendor
at or prior to Closing pursuant to this Agreement or otherwise required in connection herewith.

 

    	 

    	 

    

 

ARTICLE III

 

REPRESENTATIONS AND WARRANTIES OF THE VENDOR

 

The Vendor represents and warrants to the Purchaser that:

 

Section 3.01       Existence and Power. The
Vendor is duly incorporated, validly existing, in good standing and qualified to do business under the laws of the jurisdiction
of its organization.

 

The Vendor has all corporate power and
authority and all governmental licenses, authorizations, permits, consents or approvals to conduct its business and to own its
property as presently owned and conducted except where the failure to have such power or authority, or licenses, authorizations,
permits, consents or approvals, either individually or in the aggregate, would not be reasonably likely to have a Material Adverse
Affect on the Vendor or the Business.

 

No person has any agreement, option, understanding
or commitment or any right or privilege, whether by law, pre-emptive or contractual, capable of becoming an agreement, option or
commitment, for the purchase or acquisition from any the Vendor of any of the Purchased Assets or any rights or interest therein,
other than in the ordinary course of business.

 

Section
3.02       Authorization. The execution, delivery and performance by the Vendor of
this Agreement and any agreements, documents or instruments to be executed and delivered in connection herewith and
therewith by the Vendor and the consummation of the transactions contemplated hereby and thereby are within the Vendor's
powers and have been duly authorized by all necessary action on the part of the Vendor. This Agreement and any agreements,
documents or instruments to be executed and delivered in connection herewith and therewith by the Vendor have been duly
executed and delivered by the Vendor and constitute the legal, valid and binding obligations of the Vendor, enforceable
against the Vendor in accordance with their respective terms. Neither the execution, delivery and performance by the Vendor
of this Agreement and any other agreements, documents and instruments to be executed and delivered in connection with this
Agreement, nor the consummation of the transactions contemplated hereby and thereby will conflict with, constitute
a violation or breach of, constitute a default or give rise to any right of termination or acceleration of any right or
obligation of the Vendor under, or result in the creation or imposition of any Lien upon any properties, assets or business
of the Vendor by reason of the terms of, (i) any contract, lease, agreement, indenture, or other instrument to which the
Vendor is a party or which is binding upon such entity or any of its properties, (ii) any judgment, law, statute, rule or
governmental regulation applicable to the Vendor or any of its properties, or (iii) the articles of incorporation or by-laws
(or other organizing instruments) of the Vendor, except in any such case where such violation, breach, default or right of
termination or acceleration does not and will not have a Material Adverse Effect on Vendor or the Business.

 

Section 3.03       Subsidiaries.
There are no subsidiaries of the Vendor.

 

Section 3.05       Required Consents and Approvals.
Except as set forth on Schedule 3.04 of the Disclosure Schedule, no consent, approval, authorization, license or order
of, registration or filing with, or notice to, any government body of any country or any provincial, state, municipal or political
subdivision thereof or any entity, body or authority exercising executive, legislative, judicial, regulatory or administrative
functions of or pertaining to government, including, without limitation, any industry self-regulatory organizations or other quasi-governmental
entity (each, a “Governmental Authority”) or other third party (such consents, approvals, authorizations, licenses,
orders, registrations, filings or notices being referred to collectively as “Consents”) is necessary to be obtained,
made or given by the Vendor to or from any Governmental Authority or other third party in connection with the execution and delivery
by the Vendor of this Agreement or the consummation of the transactions contemplated hereby. “Consents” may be addressed
and obtained in the manner and form contemplated in Schedule 3.04.

 

Section 3.06       Liabilities; Undisclosed
Liabilities.At or prior to closing the Vendor will deliver a sworn statement of its then current creditors in accordance
with the Bulk Sales Act (Ontario). There shall be no liabilities of the Vendor not disclosed on such sworn statement. All
creditors on such list shall have been paid at or before closing, or shall be paid from proceeds of closing, or shall have waived
any rights to claim against the Purchaser or any of the Purchased Assets. At the Purchaser’s sole option, the Purchaser may
waive strict compliance with the Bulk Sales Act (Ontario) provided that on the Date of Closing, the Vendor executes and
delivers an indemnity in the form acceptable to the Purchaser, with respect to all costs, expenses, damages and losses which
the Purchaser may incur or suffer as a result of the Vendor’s non-compliance with the Bulk Sales Act (Ontario).

 

    	 

    	 

    

 

Section 3.07       Absence of Certain Changes.
Except for the transactions contemplated hereby and except as disclosed in Schedule 3.06 of the Disclosure Schedule
from XXXX through the Date of Closing the Vendor:

 

(a)          has
and shall carry on the Business in the ordinary course consistent with past practices and in the best interest of the Business;

 

(b)          has
used and shall use its best efforts to preserve the Goodwill with its suppliers, employees, clients/customers, and others having
business relations with it;

 

(c)          has
made and shall make no material change in the compensation of any employee of the Business who is being offered employment by the
Purchaser;

 

(d)          other
than in the ordinary course and in conformity with past practices, the Vendor has and shall (i) enter into no material contracts
or commitments, (ii) waive no material rights, (iii) enter into no other material transactions affecting the Business, the Purchased
Assets, or the Premises, without the prior written consent of the Purchaser;

 

(e)          there
has been no damage, destruction or loss, labour trouble or other event, development or condition of any character, whether or not
covered by insurance, materially and adversely affecting the Purchased Assets.

 

The Vendor shall, from the date hereof
until the Date of Closing, forthwith, after becoming aware of the same, disclose to the Purchaser in writing in reasonable detail
any event, circumstance or statement of facts (including any omission to act) that occurs between the date of this Agreement and
the Date of Closing which has or could have a material adverse effect on the Business.

 

Section 3.08       Contracts.

 

(a)          Schedule
2.02 contains a list of all Contracts, true copies of which have been provided to the Purchaser.

 

(b)          Except
as set forth in Schedule 3.07 of the Disclosure Schedule: (i) each of the Contracts is a legal, valid and binding agreement of
the Vendor and, to the knowledge of the Vendor, of the other parties thereto, and is in full force and effect; (ii) each Contract
is enforceable in accordance with its terms against the Vendor and, to the knowledge of the Vendor, enforceable in accordance with
its terms against all other parties thereto, and, the Vendor has fulfilled all of its obligations under the Contracts due on or
before the Closing and has taken all action reasonably necessary to be taken to enable it to fulfill when due all of its other
obligations under the Contracts; (iii) there is not existing any default on the part of the Vendor (or, to the knowledge of the
Vendor, any event or condition which, with notice or the lapse of time or both, would constitute a default on the part of any other
party) under any Contract; (iv) neither the Vendor nor, to the knowledge of the Vendor, any other party is in arrears in respect
of the performance or satisfaction of the terms or conditions on its part to be performed or satisfied under any of the Contracts,
and no waiver or indulgence will have been granted by any of the parties thereto; and (v) no consent is required from any third
party.

 

(c)          Except
as disclosed on Schedule 3.07 of the Disclosure Schedule, the Vendor is not a party to any (i) contract, (ii) agreement, (iii)
plan or (iv) other arrangement which materially relates to, or materially affects, the business and operations of the Business.

 

(d)          The
Vendor is not in default or breach of any obligation under any contract, agreement, commitment, indenture or other instrument,
whether written or oral, to which the Vendor, or any one of them, is a party or by which the Vendor is bound which relate to the
Purchased Assets nor is there a state of facts which, after notice of lapse of time or both, will constitute such a default or
breach.

 

Section 3.09       Litigation. Except
as disclosed on Schedule 3.08 of the Disclosure Schedule, (a) the Vendor is not a party to any, and there are no pending
or, to the Vendor's knowledge, material threatened, legal, administrative, arbitral or other proceedings, claims, actions or governmental
or regulatory investigations or proceedings of any nature against the Vendor or, to the Vendor's knowledge, any director or executive
officer of the Vendor, (b) the Vendor is not bound by or subject to any order, judgment or decree entered in any lawsuit or other
proceeding, and (c) the Vendor is not aware of any existing ground on which any action, suit or proceeding might be commenced with
any reasonable likelihood of success.

 

    	 

    	 

    

 

Section 3.10       Compliance
with Laws and Court Orders.

 

(a)          Except
as disclosed on Schedule 3.09 of the Disclosure Schedule, the Vendor is not knowingly in violation of any law, rule, regulation,
judgment, injunction, order or decree applicable to it or its assets and the operations and business of the Vendor have been conducted
in compliance in all material respects with all applicable laws, regulations and other requirements of all Governmental Authorities
having jurisdiction over the Vendor.

 

(b)          The
Vendor has filed all required forms, reports, registrations, notices, applications and other documents, together with any amendments
required to be made with respect thereto and all fees and assessments due and payable in connection therewith, required to be filed
with any Governmental Authority which is charged with regulating or supervising any business conducted by the Vendor, each of which
complied in all material respects with applicable requirements in effect on the dates of such filings.

 

Section 3.11       Assets.

 

(a)          Except
as listed in Schedule 3.10 of the Disclosure Schedule, the Vendor has and will deliver to the Purchaser good, valid and marketable
title to, or in the case of any leased property, has valid leasehold interests in, all of the Purchased Assets free and clear of
all Liens, except Permitted Liens.

 

(b)          Except
as disclosed in the Disclosure Schedule, the Vendor (i) does not own any real property which is used by the Business and (ii) is
not a party to any lease, contract or similar agreement or other arrangement which relates to leased property that is used by the
Business.

 

(c)          The
assets are free of defects and in good working order and repair, normal wear and tear excepted and have been maintained in accordance
with applicable manufacturer’s guidelines.

 

Section 3.12       Computer Hardware, Intellectual
Property, Goodwill, etc. Schedule 2.02 lists all Computer Hardware and Software owned or leased by the Vendor and used
in the Business, all Intellectual Property and items comprising Goodwill used by the Vendor in the Business.

 

(b)          At
the Closing, all Software and software license agreements will be in the Vendor’s name, and all applicable software license
agreements will be valid and binding obligations of all parties thereto, in good standing, fully paid up to the time of Closing,
and enforceable in accordance with their terms.

 

(c)          The
Vendor either (1) owns the entire right, title and interest in and to the Intellectual Property free and clear of all Liens, or
(2) has the right to use the same in perpetuity and without any obligation to pay royalties therefore, and to assign all rights
of the Vendor to the Purchaser.

 

(d)          To
the best of the Vendor's knowledge, the Business does not infringe upon, misappropriate, dilute, violate or constitute the unauthorized
use of (either directly or indirectly such as through contributory infringement or inducement to infringe) any Intellectual Property
rights owned or controlled by any third party. To the best of Vendor's knowledge, no third party is misappropriating, infringing,
diluting or violating any Intellectual Property owned or used by the Vendor and no such claims, suits, arbitrations or other adversarial
proceedings have been brought or threatened against any third party by Vendor.

 

(e)          The
Vendor has taken commercially reasonable measures to protect the confidentiality of Trade Secrets used in the Business, including
requiring its employees and other parties having access thereto to execute written non-disclosure agreements. To the best of the
Vendor's knowledge, no Trade Secret used in the Business has been disclosed or authorized to be disclosed to any third party other
than pursuant to a non-disclosure agreement or other obligation of confidentiality. To the best of the Vendor's knowledge, no party
to any non-disclosure agreement relating to its Trade Secrets is in breach or default thereof.

 

(f)          No
current or former partner, director, officer, consultant, or employee of the Vendor (or any of their respective predecessors in
interest) will, after giving effect to the transactions contemplated herein, own or retain any rights to use any of the Intellectual
Property owned or used by or on behalf of Vendor.

 

    	 

    	 

    

 

(g)          The consummation of the transaction
contemplated hereby will not result in the loss or impairment of the Vendor's right to own or use any of the Intellectual
Property used in the Business, nor will it require the consent of any governmental authority or third party in respect of any such
Intellectual Property except as disclosed on Schedule 3.11 of the Disclosure Schedule.

 

Section 3.13       Employees;
Labor Relations

 

		(a)	Schedule 5.05 sets forth:

 

		(1)	The names and titles of all officers, directors and employees
of the Business as of the date hereof.

 

		(2)	None of the employees of the Business is represented
by any labor organization and the Vendor does not have any knowledge of any union organizing activities or negotiations with respect
to employees of the Business.

 

		(3)	The Vendor is not party to any agreements (including
collective bargaining agreements, work rules or practices) with, and to the knowledge of the Vendor, there are not any pending
petitions for recognition of, a labor union or association as the exclusive bargaining agent for any or all of the employees of
the Business, and no such petitions are pending.

 

		(4)	The Vendor has been and is, with respect to employees
of the Business, in compliance in all material respects with all applicable laws respecting employment and employment practices,
terms and conditions of employment, wages, hours of work and occupational safety and health.

 

		(5)	There is no unfair labor practice charge or complaint,
grievance or arbitration under any collective bargaining agreement, discrimination or equal employment opportunity charge or complaint,
or other complaint or proceeding pending, or to the knowledge of Vendor, threatened by or on behalf of any present or former employee
of the Business or applicant for employment by the Business.

 

		(6)	There is no labor strike, dispute, lock-out, slowdown
or stoppage pending or, to the knowledge of Vendor, threatened against or affecting the Business, nor has there been any such
activity in the past.

 

		(7)	To the knowledge of the Vendor, no Governmental Authority
is conducting or intends to conduct any investigation of employment conditions or practices of the Business.

 

		(b)	All levies under the Workplace Safety and Insurance Act
(Ontario), as amended, have been paid by the Vendor up to an including the Closing Date;

 

Section 3.14       Employee Benefits. The
Vendor has no employee benefit plans, arrangements or agreements with its employees and no payments are due and payable
now nor after Closing under any plans of such nature, other than as may be set out in Section 5.05.

 

Section 3.15       Tax Representations. The
Vendor represents and warrants to Purchaser that except as set forth on Section 3.14 of the Disclosure Schedule:

 

(a)          The Vendor has filed (or had
filed on its behalf) all material Tax Returns required to be filed by it and has paid (or had paid on its behalf), or has
set up an adequate reserve for the payment of, all Taxes required to be paid (whether or not shown to be due on such Tax Returns).
All such Tax Returns are true, correct and complete in all material respects.

 

    	 

    	 

    

 

(b)          No
assessments, claims or deficiencies for any Taxes or adjustments for any amount of Tax have been proposed, asserted or assessed
against the Purchased Assets, or the Vendor, and no audit, administrative, judicial or other proceeding with respect to Taxes due
from the Vendor or with respect to the Purchased Assets is pending or being conducted and the Vendor has received no notice of
any intention to open such a proceeding.

 

(c)          Proper
and accurate amounts have been withheld, collected or deposited by the Vendor from its employees, independent contractors, creditors,
stockholders or other third parties in compliance with the Tax withholding provisions of applicable Federal, provincial, state,
municipal and local laws and have been paid over to the appropriate taxing authorities.

 

(d)          There
are no material Tax Liens upon any property or assets of the Vendor except Permitted Liens.

 

(e)          The
Vendor has collected all material sales and uses Taxes required to be collected and has remitted, or will remit on a timely basis,
such amounts to the appropriate Governmental Authorities, or has furnished properly completed exemption certificates and has maintained
all material records and supporting documents in the manner required by all applicable sales and uses Tax statutes and regulations
for all periods for which the statute of limitations has not expired.

 

(f)          The
Vendor has not waived any statute of limitations in respect to Taxes or agreed to any extension of time with respect to a Tax assessment
or deficiency which remains open or with respect to any Tax Return which has not since been filed.

 

(g)          The
Vendor is not a non-resident of Canada within the meaning of the Income Tax Act, R.S.C. 1985, as amended.

 

Section 3.16       Environmental Matters.
The Vendor (with respect to the Business) is currently in full compliance with all federal, provincial, state, municipal,
local and foreign laws, ordinances, regulations and orders relating to the protection of the environment applicable to their properties,
facilities and operations and has never been the subject of any compliance order or claim asserting non-compliance. Such compliance
includes, but is not limited to, the possession by the Vendor of all permits and other governmental authorizations required under
all applicable environmental laws, and compliance with the terms and conditions thereof.

 

Section 3.17       Brokers. There is no
broker, investment banker, finder, financial advisor or other person which has been retained by or is authorized to act
on behalf of the Vendor who might be entitled to any fee or commission for which the Vendor is liable in connection with the transactions
contemplated by this Agreement.

 

Section 3.18       Disclosure. No representation
or warranty by or on behalf of the Vendor contained in this Agreement, and no representation, warranty or statement by or
on behalf of the Vendor contained in any certificate or schedule furnished or to be furnished at the Closing to Purchaser pursuant
to this Agreement, contains any untrue statement by or on behalf of the Vendor of a material fact or omits to state any material
fact necessary to make any statement herein or therein in light of the circumstances under which they were made, not misleading.

 

Section 3.18       Full and True Disclosure.
All information relating to or concerning the Vendor and the Business set forth in this Agreement, including, without
limitation, in the Disclosure Schedules hereto, is true and correct in all material respects and the Vendor has not omitted to
state any material fact necessary in order to make the statements made herein or therein, in light of the circumstances under which
they were made, not misleading.

 

Section 3.19       Assets Necessary to the
Business. Except as set forth on Schedule 3.18 of the Disclosure Schedule, following the Closing, the assets
(including the Purchased Assets) transferred to Purchaser pursuant to this Agreement will constitute all of the assets necessary
or required to permit Purchaser to carry on the Business in substantially the same manner as presently conducted. The assets have
been maintained in such manner and are in operating condition and repair (subject to normal wear and tear) that are adequate and
sufficient for the current operations of the Business.

 

Section 3.20       Leases.
As of the Closing Date, the Lease among the Vendor and 201257 Ontario Inc. shall be terminated.

 

    	 

    	 

    

 

Section 3.21       Information Records and
Data. All information, records and data, including without limitation sales data relating to the operations of
each the Vendor furnished to the Purchaser and its representatives are true, complete and accurate in all material respects and
all financial data including financial statements provided to the Purchaser have been prepared in accordance with Canadian Generally
Accepted Accounting Principles applied on a consistent basis with previous financial years. Such financial statements are true,
correct and complete in all material respects and present fairly and in all material respects the financial condition and revenues,
expenses and results of the operations of each Vendor as of and to the date hereof.

 

ARTICLE IV

 

REPRESENTATIONS AND WARRANTIES OF PURCHASER

 

The Purchaser represents and warrants to the Vendor that:

 

Section 4.01       Existence and Power. The
Purchaser is duly incorporated, validly existing, in good standing and qualified to do business under the laws of the jurisdiction
of its organization. The Purchaser has all power and authority and all governmental licenses, authorizations, permits, consents
and approvals to conduct its business and to own its property as presently owned and conducted except where the failure to have
such power or authority, or licenses, authorizations, permits, consents or approvals, either individually or in the aggregate,
would not be reasonably likely to have a Material Adverse Effect on the Purchaser.

 

Section 4.02       Authorization. The
execution, delivery and performance by the Purchaser of this Agreement and any agreements, documents or instruments to be
executed and delivered in connection herewith and therewith by the Purchaser and the consummation of the transactions contemplated
hereby and thereby are within its powers and have been duly authorized by all necessary action on the part of the Purchaser. This
Agreement and any agreements, documents or instruments to be executed and delivered in connection herewith and therewith by the
Purchaser will be duly executed and delivered by the Purchaser and, and constitute the legal, valid and binding obligations of
the Purchaser, enforceable against the Purchaser, in accordance with their respective terms. Neither the execution, delivery and
performance by the Purchaser of this Agreement and any other agreements, documents and instruments to be executed and delivered
in connection with this Agreement, nor the consummation of the transactions contemplated hereby and thereby will conflict with,
constitute a violation or breach of, constitute a default or give rise to any right of termination or acceleration of any right
or obligation of the Purchaser under, or result in the creation or imposition of any Lien upon any properties, assets or business
of the Purchaser by reason of the terms of, (i) any contract, lease, agreement, indenture, or other instrument to which the Purchaser
is a party or which is binding upon the Purchaser or any of its properties, (ii) any judgment, law, statute, rule or governmental
regulation applicable to the Purchaser or any of its properties, or (iii) the articles of incorporation or by-laws (or other organizing
instruments) of the Purchaser, except in any such case where such violation, breach, default or right of termination or acceleration
does not and will not have a Material Adverse Effect on the Purchaser.

 

Section 4.03       Required Consents and Approvals.
No consent or approval is necessary to be obtained, made or given by the Purchaser or any of its Subsidiaries to or
from any Governmental Authority or other third party in connection with the execution and delivery by the Purchaser of this Agreement,
or the consummation of the transactions contemplated hereby.

 

Section 4.04       Brokers. There is no
broker, investment banker, finder, financial advisor or other person which has been retained or is authorized to act on
behalf of Purchaser who might be entitled to any fee or commission for which the Vendor is liable in connection with the transactions
contemplated by this Agreement.

 

Section 4.05       Issued and Outstanding Shares. The Purchaser
represents and warrants that as of the date of this agreement and as of the Closing prior to the issuance of the shares
contemplated in Article 2.06 hereof, there are 43,000,000.00 +/- 5%. issued and outstanding common shares in the capital of the
Corporation (the “Purchaser’s Share Capital”). Purchasers Transfer Agent must provide detailed schedule to be
attached to this document in Schedule 5.06.

 

    	 

    	 

    

 

ARTICLE V

 

COVENANTS

 

Each of the Parties agrees that:

 

Section 5.01       Due Diligence. The
Vendor shall permit the Purchaser access to all aspects of the Business and its records at all times prior to the Date of
Closing to permit the Purchaser to complete its due diligence review ofhte Business and the Purchased Assets.

 

Section 5.02       Confidentiality.

 

(a)          Vendor
shall not, directly or indirectly, at any time following the Closing, use the Business Confidential Information for any purpose
whatsoever or disclose the Business Confidential Information to any third party unless required by law, and it is understood that
upon Closing said Business Confidential Information shall be the sole property of Purchaser.

 

(b)          All
Business Confidential Information disclosed by Vendor to Purchaser prior to Closing, shall be held as confidential information
of Vendor, to be used only for purposes of evaluating the purchase of the Business and to facilitate the Purchaser’s obligations
under this Agreement, and otherwise kept confidential by the Purchaser pending the Closing, and if the Closing does not occur for
any reason, the Purchaser will continue to be bound by obligations of confidence in respect of the Business Confidential Information,
so long as such information is not disclosed to or obtained by Purchaser other than through a breach of this or another confidentiality
agreement.

 

Section 5.03       Lockup.

 

From the date hereof until the Date of
Closing, the Vendor, and its shareholders, officers and directors agree that they will not entertain, solicit or enter into any
other offers, agreements or negotiations for or with respect to the sale or granting rights or options to purchase the Purchased
Assets, the Business or the Vendor. Each of the Vendor and its shareholders confirms that no Person other than the Purchaser has
any agreement, option or right capable of becoming an agreement or option for the purchase from the Vendor of the Purchased Assets
or the Business.

 

Both the Vendor and the Purchaser undertake
not to disclose the terms of this Agreement and pending transaction to any person aside from employees, and as reasonably required
to complete the transaction.

 

Section 5.04       Conduct
of the Business.

 

From the date hereof until the Date of
Closing, except as otherwise provided in this Agreement or consented to or approved by Purchaser, Vendor:

 

		(a)	shall carry on the Business in the ordinary course consistent
with past practices;

 

		(b)	use its best efforts to preserve the Goodwill with its
suppliers, employees, clients / customers, and others having business relations with it;

 

		(c)	make no material change in the compensation of any employee
of the Business who is being offered employment by the Purchaser;

 

		(d)	other than in the ordinary course and in conformity with
past practices, the Vendor shall: (i) enter into no material contracts or commitments, (ii) waive no material rights, (iii) enter
into no other material transactions affecting the Business, the Purchased Assets, or the Premises.

 

    	 

    	 

    

 

The Vendor shall between the date of this
Agreement and the Date of Closing, forthwith after becoming aware of the same, disclose to the Purchaser in writing in reasonable
details any event, circumstance or statement of facts (including any omission to act) that occurs between the date of this Agreement
and the Date of Closing which has or could have a material adverse effect on the Business.

 

Section 5.05       Employment
Matters.

 

(a)       The Vendor shall terminate all
employees of the Business and shall be liable for the payment of all legal obligations relating to the termination of employment.
The Vendor’s liability shall extend to all amounts required either by statute or at common law to be paid to all employees
including pay in lieu of notice, termination pay, severance pay, vacation pay and all other outstanding amounts.

 

Section 5.07       Further Assurances. Each
Party agrees to use reasonable best efforts to execute and deliver such documents, certificates, agreements and other writings
and to use reasonable best efforts to take such other actions as may be necessary or desirable in order to consummate or implement
expeditiously the transactions contemplated by this Agreement.

 

Section 5.08       Certain Filings. The
Parties shall cooperate with one another (i) in determining whether any action by or in respect of, or filing with, any
Governmental Authority is required, or any actions, consents, approvals or waivers are required to be obtained from parties to
any material contracts, in connection with the consummation of the transactions contemplated by this Agreement and (ii) in taking
such actions or making any such filings, furnishing information required in connection therewith and seeking timely to obtain any
such actions, consents, approvals or waivers.

 

Section 5.09       Public Announcements. The
Parties agree to consult with each other before issuing any press release or making any public statement with respect to
the transactions contemplated herein.

 

Section 5.10       Non-Competition. At
Closing, the Vendor and its respective officers, directors and shareholders shall sign a binding a non-competition agreement
with the Purchaser whereby they each agree that they will not, from and after the Closing until the fifth (5th) anniversary of
the Date of Closing (or for those shareholders or directors being employed by the Purchaser, the 5th anniversary from
the date of the termination of their employment/consulting relationship with the Purchaser), directly or indirectly carry on any
business or be involved in any capacity with, including as financier to, any business of a nature which is the same or similar
to the Business or is in direct or indirect competition with the Business within Canada [NTD. Check jurisdiction]; or directly
or indirectly solicit any of the customer or employees of the Business. Passive investments in public companies where that investment
constitutes less than 2.5% of the ownership of the public company are excepted, and will not be considered a breach of this agreement.
The non-competition agreements referenced in this are referred to herein each as a “Non-Compete Agreement” and
collectively as the “Non-Compete Agreements”. Notwithstanding the foregoing, the Non-Compete Agreement for Robert
Tallack shall be limited to the business of sports pain relief and vitamins.

 

Section 5.11       Releases. Vendor shall
obtain at or before the Closing the written release and waiver from all appropriate Persons of any and all Liens imposed
on the Purchased Assets.

 

Section 5.12       Severance Obligations.
Vendor shall be solely responsible for all payments, including, but not limited to, termination, severance, unemployment
compensation, golden parachute or other payments as may be required by law becoming due to any director, officer or any employee
of the Business which arise as a result of the execution and delivery of this Agreement or the consummation of the transactions
contemplated herein.

 

Section 5.13       Lease/Real Estate.
With respect to any leased property in which the Business operates, on the Date of Closing, the leases shall be in good
standing if applicable.

 

    	 

    	 

    

 

ARTICLE VI

 

CONDITIONS TO CLOSING

 

Section 6.01       Conditions to Obligations
of Purchaser. The obligation of Purchaser to consummate the Closing is subject to the satisfaction at or prior to the
Closing of the following conditions, each of which may be waived by Purchaser in whole or in part at any time:

 

		(a)	Each of the representations and warranties of the Vendor
contained or referred to in this Agreement shall be true and correct in all material respects on the Date of Closing;

 

		(b)	The Vendor’s and Purchaser’s boards of directors
shall have provided necessary consents to the purchase and sale contemplated herein;

 

		(c)	The Vendor shall have complied with the provisions of
the Bulk Sales Act R.S.O. 1990, as amended, including delivery to the Purchaser a statement listing each Vendor’s
secured and unsecured trade creditors of the Business in the form prescribed by the Bulk Sales Act;

 

		(d)	Except as otherwise provided herein, between the date
hereof and the Date of Closing there shall have been no Material Adverse Change in the affairs, assets, liabilities, condition
(financial or otherwise) of the Business, Premises, and the Purchased Assets;

 

		(e)	The Vendor (as applicable) shall have delivered to the
Purchaser a Purchase Certificate pursuant to the Workplace Safety and Insurance Act (Ontario);

 

		(f)	The Vendor shall have delivered to the Purchaser a clearance
certificate pursuant to section 6 of the Retail Sales Tax Act (Ontario);

 

		(g)	Vendor shall have performed in all respects all of its
obligations and covenants under this Agreement required to be performed by it on or prior to the Date of Closing, and made all
deliveries required by Section 2.09;

 

		(h)	Vendor shall have delivered written agreements with each
creditor evidencing settlement of the Trade Payables for an all inclusive sum of Fifty-Five Thousand Dollars ($55,000.00) to be
paid on or immediately after the Closing of this transaction;

 

		(i)	There shall not be pending or threatened any order, decree,
judgment or litigation by any Governmental Authority seeking to enjoin or prohibit the consummation of the transactions contemplated
by this Agreement or to impose substantial restrictions on the Business or the Purchased Assets, nor shall there be any injunction
with respect to such consummation;

 

		(j)	This Agreement, the Non-Competition Agreements, and all
other closing deliveries shall have been executed and delivered by the parties thereto and shall be in full force and effect;

 

		(k)	The Purchaser shall have received or obtained any and
all consents required (a) to sell, purchase (as applicable) and operate the Business, and (b) under any material contracts, leases
or agreements to which the Vendor is a party and which require the consent of any other party thereto to the transactions contemplated
by this Agreement; and

 

		(l)	Robert Tallack shall have entered into a mutually agreeable,
non-exclusive consulting agreement whereby he shall serve as consultant to the Purchaser, or such other entity the Purchaser may
direct in writing, for a minimum term of twelve (12) months;

 

		(m)	The Purchaser has negotiated a fresh license agreement
with ABG TapouT LLC on terms and conditions acceptable to the Purchaser;

 

		(n)	The insurance for the Business is assigned to the Purchaser
conditional on such insurance being assignable; and

 

    	 

    	 

    

 

		(o)	The United States Patent No. 6,444,238 Pain Relief Composition
and Method of Relieving Pain DBC File No. R1261.101.101 including all associated formulation worksheet has been renewed for a
period of at least one year following its current expiry date of March 3, 2014 and transferred to the Purchaser.

 

Section 6.02         Conditions to Obligations
of Vendor. The obligation of Vendor to consummate the Closing is subject to the satisfaction at or prior to the Closing
of the following conditions, each of which may be waived by Vendor in whole or in part at any time:

 

(a)          Purchaser
shall have performed in all respects all of its obligations and covenants under this Agreement required to be performed by it on
or prior to the Date of Closing, and made all deliveries required by Section 2.10;

 

(b)          Each
of the representations and warranties of the Purchaser contained or referred to in this Agreement shall be true and correct in
all material respects on the Date of Closing.

 

ARTICLE VII

 

SURVIVAL AND INDEMNIFICATION

 

Section 7.01         Survival. Except as
provided in Article VIII, the representations and warranties of the Parties contained in this Agreement shall survive the
Closing, for a period of twenty-four (24) months, subject to any applicable statutes of limitations. Notwithstanding the preceding
sentence, any representation or warranty in respect of which indemnity may be sought under this Agreement shall survive the time
at which it would otherwise terminate pursuant to the preceding sentence, if notice of the inaccuracy thereof giving rise to such
right of indemnity shall have been given to the Party against whom such indemnity may be sought prior to such time. Notwithstanding
the foregoing, any indemnification with respect to Taxes shall be made pursuant to Article VIII hereof.

 

Section 7.02         Indemnification.

 

Vendor shall indemnify Purchaser and its
affiliates, directors, officers, employees, controlling persons, agents and representatives and their successors and assigns (collectively,
the “Purchaser Indemnitees”) against and hold each of them harmless from any and all claims, damage, loss, liability
and expense (including, without limitation, reasonable expenses of investigation and reasonable attorneys' fees and expenses in
connection with any action, suit or proceeding) (“Damages”) incurred or suffered by the Purchaser Indemnitees
(whether originally asserted against or imposed on the Purchaser Indemnitees by a third party or originally incurred or suffered
directly by the Purchaser Indemnitees) arising out of: (i) any breach of or any inaccuracy of any representation or warranty contained
in this Agreement, or in any agreement, certificate or other document delivered pursuant hereto; (ii) any breach or non-performance
by the Vendor of any covenant to be performed by it that is contained in this Agreement or any agreement, certificate or other
document delivered pursuant hereto; (iii) the operation of the Business by the Vendor prior to the Date of Closing; and (iv) any
liabilities incurred by the Purchaser relating to the Vendor’s failure to satisfy all liabilities relating to the Business
for the period up to the Date of Closing.

 

The Purchaser shall indemnify Vendor and
its affiliates, directors, officers, employees, controlling persons, agents and representatives and their successors and assigns
(collectively, the “Vendor Indemnitees”) against and hold each of them harmless from any and all damage, loss,
liability and expense (including, without limitation, reasonable expenses of investigation and reasonable attorneys' fees and expenses
in connection with any action, suit or proceeding) incurred or suffered by the Vendor Indemnitees arising out of: (i) any breach
of or any inaccuracy of any representation or warranty contained in this Agreement or in any agreement, certificate or other document
delivered pursuant hereto; (ii)any breach or non-performance by the Purchaser of any covenant to be performed by it that is contained
in this Agreement or any agreement, certificate or other document delivered pursuant hereto.

 

Except as provided in Article VIII of this
Agreement, and except for liability for environmental clean-up obligations, the maximum indemnity obligation of the Vendor or Purchaser
shall not exceed the amount of the Purchase Price.

 

    	 

    	 

    

 

Section 7.03         Procedures.

 

(a)          The
Person seeking indemnification under Section 7.02 (the “Indemnified Party”) agrees to give prompt notice to the Person
against whom indemnity is sought (the “Indemnifying Party”) of the assertion of any claim, or the commencement of any
suit, action or proceeding, in respect of which indemnity may be sought under such Section and will provide the Indemnifying Party
such information with respect thereto as the Indemnifying Party may reasonably request. The failure to so notify the Indemnifying
Party shall not relieve the Indemnifying Party of its obligations hereunder, except to the extent such failure shall have adversely
prejudiced the Indemnifying Party.

 

(b)          The
Indemnifying Party shall be entitled to participate in the defense of any claim asserted by any third party (“Third Party
Claim”) and, subject to the limitations set forth in this Section, shall be entitled to control and appoint lead counsel
for such defense, in each case at its expense, provided such counsel is reasonably satisfactory to the Indemnified Party.

 

(c)          If
the Indemnifying Party shall assume the control of the defense of any Third Party Claim in accordance with the provisions of this
Section 7.03, (i) the Indemnifying Party shall obtain the prior written consent of the Indemnified Party (which shall not be unreasonably
withheld) before entering into any settlement of such Third Party Claim and (ii) the Indemnified Party shall be entitled to participate
in the defense of such Third Party Claim and to employ separate counsel of its choice for such purpose. The fees and expenses of
such separate counsel shall be paid by the Indemnified Party.

 

(d)          Each
Party shall cooperate, and cause its Affiliates to cooperate, in the defense or prosecution of any Third Party Claim and shall
furnish or cause to be furnished such records, information and testimony, and attend such conferences, discovery proceedings, hearings,
trials or appeals, as may be reasonably requested by any other Party in connection therewith.

 

Section 7.04         Calculation
of Damages.

 

(a)          In
no event shall either Purchaser or Vendor be liable to the other party for any consequential damages or lost profits.

 

(b)          The
Parties hereto shall treat any indemnity payment made under this Agreement as an adjustment to the Purchase Price unless required
by law to treat such payment as other than an adjustment to the Purchase Price.

 

Section 7.05         Assignment of Claims.
If the Indemnified Party receives any payment from an Indemnifying Party in respect of any Damages pursuant to Section 7.02
and the Indemnified Party could have recovered all or a part of such Damages from a third party other than a Party (a “Potential
Contributor”) based on the underlying claim asserted against the Indemnifying Party, the Indemnified Party shall assign
such of its rights to proceed against the Potential Contributor as are necessary to permit the Indemnifying Party to recover from
the Potential Contributor the amount of such payment; provided that the Indemnified Party shall not be required to assign any right
to proceed against a Potential Contributor if the Indemnified Party determines in its reasonable discretion that such assignment
would be materially detrimental to its reputation or future business prospects.

 

Section 7.06         Exclusive Remedy. Except
as provided in Article VIII of this Agreement, the sole and exclusive remedy of the Parties with respect to claims arising
under this Agreement (except claims for non-payment of any part of the Purchase Price) shall be pursuant to the provisions of this
Article VII.

 

ARTICLE VIII

 

TAX MATTERS

 

Section 8.01         HST and Sales Tax. Any
sales tax or other transfer tax including applicable goods and services tax and provincial sales tax payable with respect
to the Purchased Assets shall be paid by the Purchaser. With respect to Retail Sales Tax (“RST”), the parties agree
that the Purchased Assets are being sold out of the ordinary course of the business of the Vendor and, accordingly, the Vendor
shall not collect RST from the Purchaser. The Vendor and Purchaser shall, on the Closing Date, elect jointly under
subsection 167(1) of the Excise Tax Act (Canada), in the form prescribed for the purposes of that subsection, in
respect of the sale and transfer of the Purchased Assets hereunder. The Purchaser shall file such election with the Canada
Revenue Agency not later than the day on which it is required to file its HST return for its reporting period which includes the
Closing Date and shall provide evidence of such filing to the Vendor.

 

    	 

    	 

    

 

Section 8.02         Tax Indemnification.
Vendor shall be responsible for, and shall indemnify and hold Purchaser Indemnitees harmless against any liability for Taxes
imposed on or with respect to the Purchased Assets for any taxable period ending on or before the Date of Closing and any Taxes
imposed on Purchaser as a result of any material breach of warranty or misrepresentation by the Vendor (which shall survive the
Closing until six months after the expiration of the applicable statute of limitations (giving effect to any waiver, mitigation
or extension thereof)) (the “Pre-Closing Taxes”) and, in each case, any liability, loss, cost or expense, including
reasonable attorneys' fees, related thereto.

 

ARTICLE IX

 

TERMINATION

 

Section 9.01         Grounds
for Termination. This Agreement may be terminated at any time prior to the Closing:

 

		(a)	by mutual written agreement of Vendor and Purchaser;

 

		(b)	by Purchaser, if the Conditions to Closing set forth
in Section 6.01 have not been fulfilled or waived by Purchaser on or before the Date of Closing;

 

		(c)	by Vendor, if the Conditions to Closing set forth in
Section 6.02 have not been fulfilled or waived by Vendor on or before the Date of Closing;

 

		(d)	by Purchaser, upon written notice to Vendor, if there
has been a material misrepresentation or breach of warranty or covenant or agreement made or to be performed by or on the part
of Vendor pursuant to this Agreement and that such misrepresentation or breach cannot be cured by the earlier of the Date of Closing
or the date thirty (30) days after receipt by Vendor of notice specifying in reasonable detail the nature of such breach, unless
Purchaser shall have previously waived such breach; or

 

		(e)	by Vendor, upon written notice to Purchaser, if there
has been a material misrepresentation or breach of warranty or covenant or agreement made or to be performed by or on the part
of Purchaser pursuant to this Agreement and that such misrepresentation or breach cannot be cured by the earlier of the Date of
Closing or the date thirty (30) days after receipt by Purchaser of notice specifying in reasonable detail the nature of such breach,
unless Vendor shall have previously waived such breach.

 

		(f)	The Party desiring to terminate this Agreement pursuant
to clauses 9.01(b), (c), (d) or (e) shall give notice in writing of such termination to the other Party.

 

Section 9.02         Effect of Termination.
If this Agreement is terminated as permitted by Section 9.01, such termination shall be without liability of any Party (or
any stockholder, director, officer, employee, agent, consultant or representative of such Party) to the other Parties to this Agreement;
provided that if such termination shall result from the willful (i) failure of a Party to fulfill a condition to the performance
of the obligations of the other Party, (ii) failure of a Party to perform a covenant of this Agreement or (iii) breach by any Party
hereto of any representation or warranty or agreement contained herein, such Party shall be fully liable for any and all Damages
incurred or suffered by the other Parties as a result of such failure or breach.

 

    	 

    	 

    

 

Section 9.03           Survival. The provisions
of Sections 2.06, 5.02, 9.02, 10.02, 10.03, 10.04, 10.10 and Article VII and Article VIII shall survive any termination
hereof pursuant to Section 9.01.

 

ARTICLE X

 

MISCELLANEOUS

 

Section 10.01         Amendments and Waivers.
Any provision of this Agreement may be amended or waived if, but only if, such amendment or waiver is in writing and
is signed, in the case of an amendment, by each of the Parties, or in the case of a waiver, by the Party against whom the waiver
is to be effective. No failure or delay by any Party in exercising any right, power or privilege hereunder shall operate as a waiver
thereof nor shall any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any
other right, power or privilege. The rights and remedies herein provided shall be cumulative and not exclusive of any rights or
remedies provided by law.

 

Section 10.02         Governing Law. This
Agreement shall be governed by and construed and interpreted in accordance with the laws of the Province of Ontario and
the laws of Canada applicable therein.

 

Section 10.03         Consent to Jurisdiction.
Each of Purchaser and Vendor irrevocably submits to the exclusive jurisdiction of the courts of the Province of Ontario
for the purposes of any suit, action or other proceeding arising out of this Agreement or any transaction contemplated hereby (and
each agrees that no such action, suit or proceeding relating to this Agreement or any transaction contemplated hereby shall be
brought by it or any of its Affiliates except in such courts). Each of Purchaser and Vendor further agrees that service of any
process, summons, notice or document by registered mail to such person's respective address set forth above shall be effective
service of process for any action, suit or proceeding in the Province of Ontario with respect to any matters to which it has submitted
to jurisdiction as set forth above in the immediately preceding sentence. Each of Purchaser and Vendor irrevocably and unconditionally
waives (and agrees not to plead or claim) any objection to the laying of venue of any action, suit or proceeding arising out of
this Agreement or the transactions contemplated hereby in the courts of Ontario or Ontario, Canada or that any such action, suit
or proceeding brought in any such court has been brought in an inconvenient forum.

 

Section 10.04         Counterparts and Fax.
This Agreement may be signed in any number of counterparts and/or facsimile, each of which shall be an original, with
the same effect as if the signatures thereto and hereto were upon the same instrument.

 

Section 10.05         Entire Agreement.
This Agreement and the exhibits and schedules hereto, together with the Letter of Intent, executed by the Parties (to the
extent not inconsistent with the terms of this Agreement), contains the entire agreement between the Parties with respect to the
subject matter of this Agreement and supersedes all prior agreements and understandings, both oral and written, between the Parties
with respect to such subject matter. No representation, inducement, promise, understanding, condition or warranty not set forth
in this Agreement has been made or relied upon by any Party.

 

Section 10.06         Binding Effect and Benefit.
This Agreement shall inure to the benefit of and be binding upon the Parties and their respective heirs, successors, legal
representatives and permitted assigns. Nothing in this Agreement, expressed or implied, is intended to confer on any Person other
than the Parties and their respective heirs, successors, legal representatives and permitted assigns, any rights, remedies, obligations
or liabilities under or by reason of this Agreement.

 

Section 10.07         Assignability. Except
as otherwise expressly provided herein, neither this Agreement nor any right or obligation hereunder may be assigned or
delegated in whole or in part by any party hereto without the prior written consent of the other party, and any such attempted
assignment or delegation without such consent shall be null, void ab initio and without effect. Any permitted assignment of this
Agreement shall be binding upon and inure to the benefit of the Parties and their respective successors and permitted assigns.

 

    	 

    	 

    

 

Notwithstanding the foregoing, Purchaser
shall be entitled to assign this Agreement or any interest it may have under this agreement to a nominee corporation to be incorporated
or designated before Closing, and upon such assignment and the undertaking of such nominee corporation to be bound hereby, Purchaser
shall have no liability to Vendor, and such nominee corporation shall be the “Purchaser” for purposes of this Agreement.

 

Section 10.08         Headings. Section
headings contained in this Agreement are for reference only and are not intended to describe, interpret, define or limit
the scope or intent of this Agreement or any provision hereof.

 

Section 10.09         No Third-Party Beneficiaries.
This Agreement is for the benefit of the Parties and is not intended to confer upon any other Person any rights or remedies
hereunder.

 

Section 10.10         Intentionally
deleted.

 

Section 10.11         Currency. Unless otherwise
indicated, all dollar amounts referred to in this Agreement are in the currency of Canada.

 

Section 10.12         Notices. Any notices
and other communications required to be given pursuant to this Agreement shall be in writing and shall be effective upon
delivery by hand or upon receipt if sent by mail (registered or postage prepaid) or upon transmission if sent by facsimile or electronic
mail (with request for confirmation of receipt in a manner customary for communications of such respective type), except that if
notice is received after 5:00 p.m., local time, on a business day at the place of receipt, or on a day which is not a business
day, it shall be effective as of the following business day. Notices are to be addressed as follows:

 

If to Revive Bioscience Inc., to:

 

Robert Tallack

Revive BioScience

 

55 Stewart St Suite 803

 

Toronto, ON, M5V 2V1

 

Email - Tallack@revivebiosci.com

 

If to Purchaser, to:

 

Axxess Pharma Inc.

2681 Eglinton Ave West

Toronto, ON, M6M 1T8

Fax:-

Email:- danielb@axxesspharmainc.com

 

or to such other respective addresses as
any Party shall designate to the others by notice in writing, provided that notice of a change of address shall be effective only
upon receipt.

 

Section 10.13         Independent Legal Advice.
Each of the Parties acknowledges that it/he/she has read and understood this Agreement and has obtained independent
legal advice in connection with this Agreement and the provisions herein, or has freely chosen not to obtain such legal advice.

 

    	 

    	 

    

 

Section 10.14       Costs. Each Party
will bear its own costs and expenses (including legal fees and disbursements) incurred in connection with this Agreement
and the transactions contemplated hereby shall be paid by the Party incurring such expenses. Each party represents that it has
not engaged any broker, finder or similar agent who would be entitled to a commission or similar fee in respect of the transaction.
The fees of any such broker, finder or similar agent engaged after the date of this Agreement will be borne by the party engaging
such finder or agent.

 

IN WITNESS WHEREOF,
the Parties have caused this Agreement to be duly executed by their respective signatures, or the signatures of their respective
authorized officers as of the day and year first above written.

 

	 	AXXESS PHARMA INC.
	 	Per:

 

	 	 	 
	 	Daniel P. Bagi, President

 

	 	REVIVE BIOSCIENCE INC.
	 	Per: Robert M. Tallack

 

	 	Robert Tallack	 
	 	Robert Tallack, President

 

	 	Date: Sept 13, 2013

 

    	 

    	 

    

 

SCHEDULE - PREMISES

 

None.

 

    	 

    	 

    

 

SCHEDULE 2.02

PURCHASED ASSETS

 

N/A

 

    	 

    	 

    

 

SCHEDULE 2.03

EXCLUDED ASSETS

 

N/A

 

    	 

    	 

    

 

SCHEDULE 2.04

TRADE PAYABLES

 

	NAME	 	VENDOR TYPE	 	AMOUNT OWING	 	 	AGREED UPON PAYMENT	 
	Facebook	 	Online media	 	$	150,000	 	 	$	4,000	 
	Sigan Industries	 	Manufacturer	 	$	26,750	 	 	$	7,000	 
	American FlexPack	 	Manufacturer	 	$	32,000	 	 	$	11,000	 
	Goldrich Printpak	 	Manufacturer	 	$	9,000	 	 	$	4,000	 
	Heenan Blaikie	 	Legal	 	$	4,000	 	 	$	4,000	 
	Heenan USA Associate	 	Legal	 	$	1,000	 	 	$	1,000	 
	AdPioneers	 	Online media	 	$	18,500	 	 	$	3,000	 
	Traffik Group	 	Marketing	 	$	14,500	 	 	$	4,000	 
	Rapid Aid	 	Manufacturer	 	$	3,000	 	 	$	3,000	 
	Optical Discs	 	Manufacturer	 	$	8,600	 	 	$	2,000	 
	Expenses imbursement	 	Operations	 	$	60,000	 	 	$	7,000	 
	Visa bill payment	 	Operations	 	$	3,500	 	 	$	3,500	 
	Liblik Design	 	Operations	 	$	14,000	 	 	$	4,000	 
	Fuller Landau	 	Accountant	 	$	2,500	 	 	$	2,500	 
	TOTAL	 	 	 	$	347,350	 	 	$	60,000	 
	 	 	 	 	 	 	 	 	$	60,000	 

 

    	 

    	 

    

 

SCHEDULE 2.06

SHAREHOLDERS ALLOCATION STATEMENT

 

	Revive BioScience	 	Shares	 	%	 	 
	Equity, Strategic	 	2,670,979	 	19.3%	 	 
	Kilambi, Raghu / Kirarv	 	2,081,839	 	15.0%	 	 
	Ltd, E52Financial	 	1,840,505	 	13.3%	 	9251 Yonge St., Suite 8285, Richmond Hill ON, L4C9T3, Canada
	Tallack, Rob	 	1,750,608	 	12.6%	 	 
	McDonnell, Tom	 	1,375,853	 	9.9%	 	1052 Highland Colony Pkwy Ste 204, Ridgeland MS 39157-8764 U
	Cameron, Calvin	 	515,637	 	3.7%	 	120 Shelter Cove Ln., Mooresville NC 28117 USA
	Hasinoff, Ian	 	515,612	 	3.7%	 	15629 Frohock Pl., Charlotte NC 28277 USA
	Yang, Cheming	 	505,687	 	3.7%	 	6318 Seton House Ln, Charlotte NC 28277-4523 USA
	Csurgo, Julius	 	350,000	 	2.5%	 	 
	Marek, Justin	 	273,761	 	2.0%	 	367 Bantry Ave, Richmond Hill ON, L4B4G1, Canada
	Henson, Anna	 	265,984	 	1.9%	 	3363 Cochise Dr SE, Atlanta GA 30339-4322 USA
	Klein, Rob	 	250,000	 	1.8%	 	 
	Gooding, Daniel	 	209,065	 	1.5%	 	1901 Queens Rd, Charlotte NC 28207-2583 USA
	Houlton, Andrew	 	202,130	 	1.5%	 	6208 Idylwood Ln, Minneapolis MN 55436-1107 USA
	Reid, Jason	 	195,000	 	1.4%	 	 
	Architects, MGP	 	182,682	 	1.3%	 	123 East St., Sault Ste Marie ON P6A3C7, Canada
	O'Neill, Liam	 	100,000	 	0.7%	 	 
	Sevic, Igor	 	55,341	 	0.4%	 	 
	Lancaster, Zosia	 	52,266	 	0.4%	 	27 Harbourview Cr., Toronto ON, M8V4A7, Canada
	Sayson, Samuel	 	52,205	 	0.4%	 	5710 Providence Country Club Dr., Charlotte NC 28277-2621 USA
	Vendor, Traffic	 	50,000	 	0.4%	 	 
	Zinn, Chad	 	50,000	 	0.4%	 	 
	Sair, Farrukh	 	48,884	 	0.4%	 	 
	Welna, Jeff	 	48,884	 	0.4%	 	3319 Lakeside Dr., Charlotte NC 28270, USA
	Marek, Earl,	 	46,117	 	0.3%	 	367 Bantry Ave, Richmond Hill ON, L4B4G1, Canada
	Shook, Paul	 	46,117	 	0.3%	 	 
	Stratford, Gordon	 	46,117	 	0.3%	 	1286 Cumnock Cres., Oakville ON L6J2N7, Canada
	Mezzomo, Gordon	 	33,000	 	0.2%	 	23 Palomino Dr., Sault Ste Marie ON P6A6K4, Canada
	Vendor, AmeriFlex	 	20,000	 	0.1%	 	 
	Joyce, Terrence	 	2,500	 	0.0%	 	2036 Millenium Crt., Sault Ste Marie ON P6C6H6, Canada
	Leon, Edward	 	2,500	 	0.0%	 	13 Eversley Hall, King City ON L7B1L8, Canada

 

    	 

    	 

    

 

3.06 Material Changes

 

None

 

3.07 Defects - Contracts

 

None

 

3.08 Litigation

 

None

 

3.09 Compliance with Laws
and Court Orders 

 

None

 

3.10 Liens

 

None

 

3.11 Deficiencies in Intellectual Property

 

None

 

3.12 Employees

 

See Schedule 5.05

 

3.13 Employee Benefits

 

See Schedule 5.05

 

3.14 Deficiencies re
Taxes

 

None

 

3.18 Other Necessary Assets

 

None

 

    	 

    	 

    

 

SCHEDULE 5.05

EMPLOYEES TO BE RETAINED

 

None.

 

    	 

    	 

    

 

SCHEDULE 5.06

CURRENT CAPITALIZATION TABLE

PROVIDED BY PURCHASER

 

NOTE: information to be provided by Purchasers Transfer Agent.

 

CHART TO INCLUDE ALL OF THE FOLLOWING:

 

		1.	Common shares

		2.	Preferred shares

		3.	Options

		4.	Warrants

		5.	Convertible debenturesDistribution Agreement

 

This Agreement is made on the __________ day of ___________
2014.

 

BETWEEN

 

		1)	Axxess Pharma Canada Inc. whose registered office is situated at 2681 Eglinton Ave
West, Toronto, Ontario M6M 1T8, Canada (hereinafter referred to as “AXXESS”)

 

- and- 

 

		2)	Hard Core Beverages LLC. whose registered office is situated at P.O. Box 4664 Robina
Town Centre | QLD | 4230 Australia (hereinafter referred to as “HCB”)

 

WHEREAS:

 

		1.	AXXESS is the owner of a world-wide exclusive license to manufacture distribute and sell various
products under the TapouT label, including topical and oral pain relief, vitamins & Minerals and nutritional supplements for
human use.

 

		2.	HCB is a distributor of TapouT-branded beverages in certain Australasian territories.

 

		3.	AXXESS wishes to appoint HCB as its exclusive distributor of certain TapouT-branded products defined
in Appendix “A” , as hereinafter defined, in the territories defined in Appendix “B”.

 

		4.	HCB desires to market, sell and distribute such Products on behalf of AXXESS in the territories
listed in Appendix “B”.

 

NOW THEREFORE, AXXESS and HCB hereby agree as follows:

 

		1.0	Operative Provisions: 

 

		1.1	Definitions: 

 

In this Agreement, unless the
context otherwise requires, the following terms or expressions shall have the following meaning;

 

		1.2	“Adverse Reactions” shall mean the suspected or alleged adverse reactions to the Product.

 

    	 

    	 

    

 

		1.3	“Products” shall mean those stipulated in Appendix “A” (as may be amended
pursuant to the terms and conditions of this Agreement).

 

		1.4	“Territory” shall mean the countries listed in Appendix “B”

 

		1.5	“Force Majeure” shall mean circumstances beyond the reasonable control of the Party
affected thereby which prevent that Party from performing some or all of its obligations hereunder, including without limitation
the following circumstances, fire, flood, accidents, war, commotion, riot, acts of God or any unlawful governmental authority.

 

		1.6	“Intellectual Property” shall mean any patent, copyright, trade name, trademark, registered
design or unregistered design right and any application for any of the foregoing, any right in respect of confidential information
and any other intellectual property rights.

 

		1.7	“Know-how” shall mean all technical data and information, however stored or presented,
with regard to the Products provided by AXXESS and HCB, including any other confidential information which has been or shall be
during the term of this Agreement disclosed by either Party to the other Party, pursuant to this Agreement.

 

		1.8	“Party” or “Parties” shall mean the parties to this Agreement.

 

		2.0	Appointment of Distributor and Term: 

 

		2.1	AXXESS hereby grants to HCB the exclusive right, license and privilege to distribute the Products
for sale in the Territory.

 

		2.2	HCB agrees to use commercially reasonable efforts consistent with industry standards to distribute
the Products in the Territory.

 

		2.3	HCB shall be entitled to describe itself as Axxess’s ‘Authorised Distributor’
for the Products in its Territory (as set out in Appendix “B”).

 

		2.4	This Agreement is effective as from the date executed by the parties (the “Effective Date”)
and shall remain in force for a period of five (5) years following the date upon which HCB receives regulatory approval to distribute
the Products in its Territory (the “Term”) unless otherwise terminated in accordance with the terms of this Agreement.
The Parties agree that this Agreement shall automatically terminate at the end of the Term unless notice of renewal for a further
term of Five (5) years is delivered by either Party at least six (6) months prior to the end of the Term, and the other Party agrees
in writing to such renewal.

 

    	 

    	 

    

 

		2.5	In the event that HCB fails to obtain regulatory approval to distribute the Products in its Territory
within One (1) year from the Effective Date, either Party shall be permitted to terminate this Agreement by delivering notice in
writing which termination shall be effective on the last day of the month in which such notice is given.

 

		2.6	HCB shall at all relevant times represent itself as the distributor for AXXESS in the Territory
and not as an agent of AXXESS;

 

		2.7	HCB and AXXESS shall comply with all legal requirements from time to time in force relating to
the storage and sale of the Products as provided by AXXESS and HCB and pursuant to the regulatory authorities in the Territory.
Upon no less than 48 (forty-eight) hours notice, AXXESS shall be permitted to enter upon the storage facilities of HCB to inspect.
In the event AXXESS should find such storage facility in contravention with its instructions or the requirements of local regulatory
requirements, AXXESS shall be permitted to provide notice to HCB to remedy such contravention(s) within seven (7) days of the date
such notice is given failing which either party shall be permitted to terminate this Agreement forthwith, to seize the Products
and to take all action against the other party to enforce the provisions hereof as are necessary.

 

		3.0	Forecast-Order-Supply: 

 

		3.1	HCB shall provide to AXXESS, in writing, at the beginning of each quarter, its estimated supply
requirements of the Products for the twelve (12) month period following the end of such quarter, broken down quarter by quarter
(“Quarterly Forecasts”), of which the last three (3) Quarterly Forecasts shall be considered to be estimates only and
not binding forecasts upon the parties. In the event that either party is in any way dissatisfied with the Quarterly Forecasts,
HCB and AXXESS agree to work cooperatively to reach mutually agreeable Quarterly Forecasts. If, as the case may be, the parties
cannot agree on Quarterly Forecasts, the parties agree that the last Quarterly Forecast approved by either party shall be considered
the valid Quarterly Forecast until a mutually agreeable Quarterly Forecast is reached.

  

    	 

    	 

    

  

		3.2	Firm orders shall be placed by HCB with AXXESS, specifying the quantity of Products ordered, the
required delivery date and the shipping instructions, at a minimum of four (4) months prior to the required shipping date. In case
a firm order exceeds substantially the prior forecast of estimated quarterly requirements as referenced under clause 3.1 hereof,
AXXESS shall deliver, at a minimum, a quantity of the Products which represents the estimated quantity and propose a delivery date
for the remaining quantity to HCB, the delivery date for total quantity.

 

		3.3	AXXESS shall use its best efforts to execute such orders for the Products in accordance with the
order specifications provided by HCB to Axxess.

 

		3.4	Each party shall in respect of each order for the Products to be supplied hereunder be responsible
for:

 

		3.4.1	ensuring the accuracy of the order placed with the other party; and

 

		3.4.2	shipping, marketing and distribution costs related to the sale of the Products in

 

the Territory.

 

		3.5	Upon receipt of an order from HCB, AXXESS shall, as soon as is practicable, provide HCB with an
estimated delivery date.

 

		3.6	Title to any of the Products delivered by AXXESS in fulfillment of any order placed by HCB, shall
remain in the name of AXXESS until such Products comprising said order have been paid for in full by HCB, after which title shall
pass to the HCB.

 

		3.7	AXXESS shall, based on Quarterly Forecasts, hold adequate stocks of packaging components.

 

		4.0	Price and Payment Conditions: 

 

		4.1	For a period of two (2) years commencing on the date of first firm order HCB shall, for the duration
of this Agreement, buy the Products exclusively from AXXESS at the price as given in this Agreement hereto. Notwithstanding the
above, in the event that production costs, market circumstances or governmental interference will necessitate a review of these
prices both parties agree to re-discuss and if necessary adapt the supply prices by mutual arrangement, in such a manner that the
Product will remain commercially acceptable to both Parties. If both Parties cannot come to an agreement on a revised price, either
Party can terminate the Supply Agreement.

 

    	 

    	 

    

 

		4.2	The current price as per Schedule I shall apply for one year. The prices are delivered duty paid
(DDP – Incoterms 2010).

 

		4.3	During the fourth quarter of each year, the parties shall negotiate and agree on the prices to
be charged by the other party during the following calendar year. In absence of such agreement, the prices shall remain unchanged
during the following calendar year.

 

		4.4	All prices for the Products are exclusive of any applicable value added or any other sales tax,
for which HCB will be additionally liable.

 

		4.5	For the avoidance of doubt, prices shall be fully inclusive of all costs incurred by either party
in the origination of designs for the Product.

 

		4.6	Both Parties shall maintain at their respective head offices in their Territory proper books and
records in relation to the matters set out in this Agreement and in accordance with generally accepted accounting principles. If
necessary, either party shall be entitled during normal business hours and upon 48 (forty-eight) hours notice, to examine at its
own expense such books and records, as long as they are related to this Agreement.

 

		4.7	HCB shall provide a quarterly report to AXXESS, delivered within Thirty (30) days of the end of
each quarter, a summary of each sale transaction in such quarter, including the name, address and contact information for each
customer and the quantity of Products sold to each customer.

 

		5.0	Regulatory Approval in Territory 

 

		5.1	HCB and AXXESS shall take all steps necessary to obtain regulatory approval for the distribution
of the Products in the Territory. HCB shall bear the full cost of all regulatory, filing and other fees incurred by it in any way
related to the TapouT branded products listed in Schedule “B” and specifically all costs associated with obtaining
regulatory approval of the Products for distribution in the Territory as listed in Schedule ”A”.

 

		5.2	AXXESS agrees to cooperate with and to use its reasonable best efforts to assist HCB in obtaining
regulatory approval of the Products for distribution in the Territory.

 

    	 

    	 

    

  

		5.3	Upon expiration of the Term or termination of this Agreement for any reason, the Parties agree
that HCB shall transfer the corresponding regulatory approval of each Product to the party appointed by AXXESS to distribute the
Products in the Territory. In the event that HCB has been authorized to sell the Product in the Territory for a period of less
than Two (2) years, AXXESS hereby agrees to pay HCB for the consideration of such transfer the sum of Five Thousand United States
Dollars (USD$5,000.00) for each regulatory approval so transferred or assigned.

 

		6.0	Marketing of the Products: 

 

		6.1	HCB shall use its best efforts to promote the sale of the Products throughout the Territory.

 

		6.2	In connection with the promotion and marketing of the Products, HCB shall; 6.2.1 advertise and
promote the Products in the Territory, at its expense, spending

 

no less than seven and a half percent (7.5%) of its
annual net sales on various means of advertising and promotion; and

 

		6.2.2	forward all advertising and promotion artwork to AXXESS for pre-approval, such approval not to
be unreasonably withheld or delayed.

 

		6.3	AXXESS hereby grants HCB an exclusive license in the Territory to use the trademarks, if any, related
to the Products for the marketing, promotion and sale of the Products.

 

		6.4	HCB may indicate, in signs, advertising, publicity, or other sales or marketing media or materials,
that it is an authorised distributor of AXXESS’ Products.

 

		7.0	Confidentiality and Non-Competition Covenants: 

 

		7.1	Each Party agrees to disclose, in its sole discretion, the Know-how and any other confidential
information to the other Party.

 

		7.2	The receiving Party agrees to accept such disclosure in strict confidence and agrees that it will
not use, for its own benefit or for the benefit of others, nor disclose to anyone not in its employ or in the capacity of the Party’s
professional advisers, except for the implementation and execution of this Agreement, any information related to such disclosure,
except to the extent that any such information can be shown by such Party:

 

		7.2.1	to be in possession or in the possession of its employee prior to such disclosure; or

 

		7.2.2	is now or hereinafter becomes available as public knowledge or literature, through no fault of
the receiving party, patented or otherwise; or

 

    	 

    	 

    

 

		7.2.3	is received from an independent third party that, to receiving party’s knowledge, did not
receive the information directly or indirectly from the disclosing party.

 

		7.3	Each Party agrees not to disclose the Know-how and/or confidential information of the other Party
to its employees, except to those requiring same for evaluation purposes related to such Party’s performance of its covenants
and obligations provided in this Agreement.

 

		7.4	The confidentiality obligations will remain in effect for Twenty (20) years following the date
of expiry or termination of this Agreement for whatever cause.

 

		7.5	Non-Competition Covenant 

 

		7.5.1	HCB and AXXESS shall not, during the Term, without the prior written consent of the other party,
directly or indirectly, in any manner whatsoever, including, without limitation, either individually or in partnership or jointly,
or in conjunction with any other person as principal, agent, shareholder, employee or in any other manner whatsoever, carry on
or be engaged in a business that manufactures, distributes or sells products that are similar to the Products (a “Competitive
Business”), or be concerned with or interested in or lend money to, guarantee debts or obligations of or permit its name
or any part thereof to be used by any person engaged or concerned with or interested in a Competitive Business in the Territory.

 

		7.5.2	HCB will not without the prior written consent of AXXESS, and for a period of five (5) years after
the expiry or termination of this Agreement (i) divulge to any person the name of any customer or client of HCB that has purchased
the Products (ii) knowingly solicit, interfere with or endeavour to entice away from AXXESS any customer, client or any person
in the habit of dealing with HCB or in purchasing the Products from HCB; and (iii) interfere with or knowingly entice away or otherwise
attempt to obtain the withdrawal of any employee of AXXESS. Notwithstanding anything provided herein, in no case shall this clause
prevent a distributor of AXXESS subsequent to the termination of this Agreement under any circumstances to solicit business from
customers of HCB that purchased the Products from HCB during the Term in relation to other products sold, distributed or manufactured
by AXXESS as long as any such other products are not considered Competitive Business.

 

    	 

    	 

    

  

		7.5.3	AXXESS may apply for or have an injunction restraining breach or threatened breach of the covenants
herein contained, and HCB shall be liable to reimburse AXXESS for all losses, expenses, costs, damages and charges or any of them
arising out of any failure of HCB to observe the covenants herein contained.

 

		7.5.4	AXXESS will not, without HCB’s prior written consent, during the Term and for Five (5) years
following the end of the Term or the date of earlier termination of this Agreement: (i) knowingly interfere with or endeavour to
entice away from HCB any customer, client or any person in the habit of dealing with HCB; and (ii) interfere with or knowingly
entice away or otherwise attempt to obtain the withdrawal of any employee of HCB. AXXESS shall be liable to reimburse HCB for all
losses, expenses, costs, damages and/or charges arising out of any failure of AXXESS to observe its obligation herein. Notwithstanding
anything provided herein, in no case shall this clause prevent a distributor of Axxess subsequent to the termination of this Agreement
under any circumstances to solicit business from customers of HCB that purchased the Products from HCB during the Term.

 

		8.0	Warranties and Liabilities: 

 

		8.1	Subject as herein provided, AXXESS warrants to HCB that;

 

		8.1.1	all Products supplied hereunder will be of a satisfactory quality and will comply with any specifications
agreed to between the Parties with respect to the Products.

 

		8.1.2	it has the legal right to license the Products for distribution and sale throughout the world and
specifically within the Territory.

 

		8.1.3	it has the legal right to license the Intellectual Property related to the Products and is therefore
authorized to grant the licenses herewith.

 

		8.1.4	that all Products sold by it to HCB shall be in conformity with the official market authorisation
in the Territory and free from defects in workmanship or materials.

 

    	 

    	 

    

 

		8.2	In the event of any breach of AXXESS’s in clause 8.1 (whether by reason of defective materials,
production faults or otherwise), AXXESS’s liability,

 

which shall be determined in accordance with sections
9.3 through 9.6 hereof,

 

shall be limited to;

 

		8.2.1	the replacement of the Products in question at AXXESSs sole cost and expense; or

 

		8.2.2	at AXXESS’s option, repayment of the purchase price or any portion thereof paid for the Products;

 

8.2.3     In the event that any
Products or parts thereof shall prove not to be safe, in conformity with the official market authorisation in the Territory or
to be defective in workmanship or materials within a period expiring on the date indicated on the package of the Products and provided
the other party is immediately informed thereof, then either party shall replace the same without cost to the other party.

 

		8.3	AXXESS and HCB agree to disclose any Safety Data to each other within the following time limits;

 

		8.3.1	for all safety data not relating to Serious Adverse Drug Experiences within five (5) business days
of receiving such Safety Data

 

		8.3.2	for Safety Data relating to Serious Adverse Drug Experiences within three (3) business days of
receiving such Safety Data

 

		8.4	The content of such disclosure of Safety Data shall comply with all applicable regulations. Each
Party shall promptly deliver to the other, all correspondence, which such party may receive from regulatory authorities in jurisdictions.

 

		8.5	Each Party shall notify the other if it becomes aware of any claims, actions or suits, losses,
liability costs or expenses alleged to be caused by or resulting from the use or consumption of the Product. AXXESS and HCB shall
consult and co-operate to the extent possible in the defence of any such claims or suits negotiations pertaining hereto.

 

		9.0	Shipping and Payment: 

 

		9.1	All shipments to HCB from AXXESS shall be EXW (Incoterms 2010) at the place of business of AXXESS
or HCB as the case may be, Products shipped shall have a minimum of twenty-four (24) months shelf life or shelf life in accordance
with local regulatory requirements as the case may be, remaining on the Product as of the delivery date of the Products.

 

    	 

    	 

    

  

		9.2	HCB is required to make payment of one hundred percent (100%) of the purchase price for all Products
on or prior to the release of the Products for shipment by AXXESS.

 

		9.3	HCB shall inspect all deliveries of the Products on arrival. Any complaint regarding qualitative
faults and/or quantitative shortcomings of the delivered Products (hereinafter “Deficiencies”) that are or should have
been obvious at delivery by visual inspection made with reasonable care, shall be made in writing by HCB to AXXESS within two (2)
business days after the receipt of the Products in their respective warehouses. If either party fails to notify the other party
of Deficiencies within such period, the receiving party shall be deemed to have accepted the shipment and shall have no further
right to claim that there were Deficiencies with such order, unless any defects are not obvious by visual inspection.

 

		9.4	Each party shall notify the other party without delay of becoming aware of any defects in the Products
that may not or would not have been obvious at delivery by visual inspection of such Products made with reasonable care.

 

		9.5	Upon being notified of Deficiencies or any other defects by either party to the other party, either
party shall have a representative from its office within Thirty (30) days to assess the Deficiencies or defects to determine the
veracity of same and if it is so determined that such Deficiencies or defects are valid, and either party shall have Thirty (30)
days thereafter to replace or apply a credit to the portion of the order that was faulty, free of charge to the other party, delivered
EXW (Incoterms 2010) at the other party’s warehouse.

 

		9.6	In the event that either party does not agree with the allegation of Deficiencies advanced by the
other party, the parties hereto shall endeavour to resolve such dispute amicably and constructively between themselves. The Parties
shall despite any such dispute at all times continue to honour their obligations pursuant to the terms and conditions of this Agreement.
The Parties agree to submit their dispute to a third party laboratory who shall finally settle such dispute. The third party laboratory
shall be a laboratory in Ontario which is mutually agreed upon by the parties acting reasonably.

 

    	 

    	 

    

  

		10.0	Reimbursement by AXXESS

 

		10.1	AXXESS shall reimburse HCB for:

 

		10.1.1	Products withdrawn from the market (from customers) based on AXXESS’ decision;

 

		10.1.2	Products for which HCB has compensated customers based on AXXESS’ decision;

 

		10.1.3	Products withdrawn from the market based on the decision of any relevant authority.

  

In the
event that HCB is required to withdraw the Product for any reason other than the fault of HCB within the first Two (2) year period
of the Term, AXXESS shall pay the sum of Five Thousand United States Dollars (USD$5,000.00) for each Product so withdrawn. For
the purpose hereof, a Product is withdrawn when its regulatory approval has been revoked and HCB is no longer able to market and
sell the Product in the Territory.

 

		11.0	Force Majeure: 

 

		11.1	If either Party is affected by Force Majeure it shall forthwith notify the other Party of the nature
and extent thereof.

 

		11.2	Neither Party shall be deemed to be in breach of this Agreement, or otherwise be liable to the
other, by reason of any delay in performance, or non-performance is due to any Force Majeure of which it has notified the other
Party; and the time for performance of that obligation shall be extended accordingly.

 

		11.3	If the Force Majeure in question prevails for a continuous period in excess of Six (6) months,
the Parties shall enter into bona fidae discussions with a view to alleviating its effects, or to agreeing upon such alternative
arrangement as may be fair and reasonable. If no agreement is reached among the Parties, either Party may terminate this Agreement
upon notice given to the other Party Fifteen (15) calendar days in advance of the effective date of termination.

 

		12.0	Termination: 

 

		12.1	Either party shall be entitled forthwith to terminate this Agreement by written notice to the other
Party, if:

 

    	 

    	 

    

  

		12.1.1	the other Party commits any breach of any of its covenants or obligations provided in this Agreement,
and in the case of a breach capable of remedy, fails to reach agreement to remedy the same within sixty (60) days after receipt
of a written notice giving full particulars of the breach and requiring it to be remedied. If a breach is not capable of remedy,
the notice shall be effective 30 (thirty) days after its receipt;

 

		12.1.2	the other Party goes into liquidation, bankruptcy or any similar procedure, whether voluntarily
or involuntarily;

 

		12.1.3	the regulatory authorization enabling the production, marketing or sale of the Product is withdrawn
or revoked by the regulatory agency governing same;

 

		12.1.4	AXXESS is no longer able to manufacture and supply the Products; or

 

		12.1.5	the other Party ceases, or threatens to cease to carry on business.

 

		12.2	AXXESS shall have the right to terminate this Agreement if HCB should, in any twelve month period,
fail to place orders with AXXESS equivalent to Eighty Percent (80%) of the cumulative quarterly forecasts which HCB provided to
AXXESS for such period in accordance with clause 3.1 hereof such termination to be effective on the last day of the quarter following
the quarter in which such notice was given.

 

		12.3	AXXESS shall have the right to terminate this Agreement if AXXESS is dissatisfied with the cumulative
Quarterly Forecasts of HCB for a twelve (12) month period, in which case termination shall be effective at the end of the twelve
(12) month period following the date the notice of termination was delivered by AXXESS.

 

		13.0	Consequences of Termination: 

 

		13.1	Upon termination of this Agreement for any reason, HCB shall:

 

		13.1.1	have the right to sell out its remaining inventory of the Product then still in its possession
during a period of up to one (1) year; and

 

		13.1.2	immediately render adequate and final accounts to AXXESS with respect to any transaction under
the present Agreement to which it has not yet rendered an accounting to AXXESS.

 

		13.2	Upon termination of this Agreement that was due to AXXESS’ breach of this Agreement, AXXESS
shall be required to buy back all or part of HCB’s inventory of the Products at HCB’s landed cost upon HCB’s
request. HCB shall, at AXXESS’ cost, ship such inventory purchased back by AXXESS to AXXESS within ten (10) business days
of HCB’s request. The payment for such inventory, and as the case may be, for shipping and handling of the Products, shall
be made by AXXESS within ten (10) business days of receipt of the returned Products.

 

    	 

    	 

    

  

		13.3	If termination of the Agreement is due to HCB’s breach of this Agreement, including but not
limited to termination pursuant to clause 3.8, 12.1 and 12.2, then HCB shall have th right to sell any surplus inventory in its
possession for a period of one quarter, upon which time any surplus inventory is returned to AXXESS free of charge.

 

		14.0	Notices: 

 

		14.1	Any notice required under this Agreement shall be made in writing and sent by telefax followed
by overnight courier to AXXESS and to HCB at their respective addresses. Notwithstanding the above, all correspondence with regard
to the termination of this Agreement shall be by overnight courier. Notices by registered mail are deemed to be given Three (3)
days of mailing. Notices by telefax shall be deemed to be given on the date on which such notices have been given.

 

		15.0	Arbitration and Applicable Law: 

 

		15.1	This agreement is governed by the laws of the State of New York, United States of America The parties
hereby exclude the applicability of the United Nations Convention on Contracts for the International Sales of Good, as in effect
from time to time.

 

		15.2	Any and all disputes arising out of or resulting from this Agreement shall be finally settled according
to the Arbitration Rules of the International Chamber of Commerce by one arbitrator named in accordance to said Rules. The language
that shall be used in the arbitration proceeding shall be English. The seat of arbitration shall be in New York City.

 

		16.0	Entire Agreement: 

 

		16.1	This Agreement constitutes the entire agreement by and between the Parties hereto with respect
to the transactions contemplated hereby, and supersedes all prior oral and/or written understandings and agreements relating thereto.
Neither Party, nor any of its agents, has made any representations to the other which the Party intend to have any force or effect,
except as specifically set forth herein. No waiver of the provisions hereof shall be effective unless in writing and signed by
the Party to be charged with such waiver. No waiver shall be deemed a continuing waiver or waiver in respect of any subsequent
breach or default, either of similar or different nature, unless expressly so stated in writing. This Agreement may not be modified
or changed in any way, except in writing signed by both of the Parties hereto.

 

    	 

    	 

    

  

		17.0	Severability: 

 

		17.1	If any term or provision of this Agreement shall be held to be invalid or unenforceable, all other
clauses, sections or parts of this Agreement which can be effected without such term or provision shall remain in full force and
effect and shall in no way be affected or impaired

 

IN WITNESS HEREOF, this AGREEMENT is executed by the Parties
in duplicate originals.

 

	FOR AND ON BEHALF OF
    AXXESS	 	FOR AND ON BEHALF OF
    HCB
	 	 	 
	 	 	 
	 	 	 
	 	 	 
	President	 	Managing Director
	 	 	 
	Date:	 	 	Date:	 

 

    	 

    	 

    

 

SCHEDULE I

 

Products

 

	-	@	$_________
	 	 	 
	-	@	$__________

 

First Year Forecast

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00233-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00233-of-00352.parquet"}]]